Protalix BioTherapeutics, Inc.
Disclosed SEC business address
2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
Protalix BioTherapeutics, Inc. (ticker PLX, CIK 0001006281) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Biological Products, (No Diagnostic Substances) (SIC 2836). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 5 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-25T06:41:18.693547+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing index · retrieved 2026-10-19T23:35:23.241012+00:00
- SEC EDGAR · issuer filing index
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.